VEGFR-2-IN-6 |
| Katalog-Nr.GC61600 |
VEGFR-2-IN-6 (Beispiel 64) ist ein VEGFR2-Inhibitor (Angiogenese-Modulator), der dem Patent WO 02/059110 entnommen ist.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 444731-47-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
VEGFR-2-IN-6 (example 64) is a VEGFR2 inhibitor (angiogenesis modulator), which is extracted from patent WO 02/059110[1].
[1]. Glaxo Wellcome House, et al. PYRIMIDINEAMINES AS ANGIOGENESIS MODULATORS. Patent WO 02/059110.
Review for VEGFR-2-IN-6
Average Rating: 5 (Based on Reviews and 2 reference(s) in Google Scholar.)
Review for VEGFR-2-IN-6
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *